You are here

cancer

Merck to acquire $1bn equity stake in Seattle Genetics; announces two oncology collaborations

Biopharma Reporter

Mon, 09/14/20 - 10:58 am

Seattle Genetics

ladiratuzumab vedotin

Esmo 2020 preview – late-breaking immunotherapy

EP Vantage

Mon, 09/14/20 - 10:53 am

Bristol-Meyers Squibb

Gilead to buy cancer drugmaker Immunomedics for $21B

BioPharma Dive

Sun, 09/13/20 - 10:26 pm

Gilead Sciences

Jazz inks Redx pact to secure 2 targeted cancer therapies

Fierce Biotech

Wed, 09/9/20 - 10:34 am

Jazz Pharmaceuticals

targeted therapies

Oncology biotech Prelude guns for $100M IPO

Fierce Biotech

Tue, 09/8/20 - 11:01 am

Prelude Therapeutics

FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures

Xconomy

Sun, 09/6/20 - 07:22 pm

Blueprint Medicines

non-small cell lung cancer

Triumvira Immunologics raises $55M in Series A funding round for new form of cancer cell therapy

MedCity News

Sun, 08/30/20 - 11:22 pm

clinical trials

Foundation Medicine wins FDA OK for pan-tumor test as liquid biopsy market heats up

BioPharma Dive

Thu, 08/27/20 - 10:11 pm

Foundation Medicine

The Inside Story Of Biotech’s Barnum And His Covid Cures

Forbes

Thu, 08/27/20 - 12:39 pm

Patrick Soon-Shiong

Kinnate Raises $98M for Human Tests of Targeted Cancer Therapies

Xconomy

Wed, 08/26/20 - 11:39 pm

Kinnate Biopharma

Vir enlists Covid-19 antibody rival for cancer, infectious disease discovery work

Endpoints

Mon, 08/24/20 - 10:43 am

Vir Biotechnology

infectious diseases

'We want to be everywhere.' Mission Bio raises $70M behind resistance-hunting sequencing platform

Endpoints

Fri, 08/14/20 - 09:45 am

single cell sequencing

Achilles Heel of Immunotherapy-Resistant Cancers Revealed – and Eliminated – in Early Studies

BioSpace

Wed, 08/12/20 - 11:47 pm

immunotherapy-resistant cancer

Sanofi, GlaxoSmithKline disclose DOJ investigation into Zantac after recalls

Fierce Pharma

Tue, 08/4/20 - 12:34 pm

product recalls

False Claims Act

Eli Lilly crashes out of KRAS race as toxicity sees it ditch phase 1 effort

Fierce Biotech

Thu, 07/30/20 - 11:11 am

KRAS inhibitors

GSK’s latest pipeline review includes a slate of COPD programs headed to the scrap heap

Endpoints

Wed, 07/29/20 - 12:41 pm

Thrive Brings in $257 Million More to Advance Cancer Liquid Biopsy Assay

BioSpace

Wed, 07/29/20 - 12:28 pm

Thrive Earlier Detection

liquid biopsies

AstraZeneca inks $6bn cancer drug deal with Daiichi Sankyo

Pharmaforum

Mon, 07/27/20 - 11:00 am

GSK’s John Fleming on rethinking oncology from the ground up

Pharmaforum

Fri, 07/24/20 - 11:23 am

Lung cancer study IDs new 'epigenomic' target for diagnosis and treatment

Fierce Biotech

Fri, 07/24/20 - 09:32 am

Pages